Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Deethyloxybutynin
2. Desethyloxybutynin
3. Desethyloxybutynin Hydrochloride
1. 80976-67-6
2. Nrx-101
3. 8809snk4f7
4. Nt0502
5. Nt-0502
6. 4-(ethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate
7. Deethyloxybutynin
8. Desethyloxybutynin
9. Unii-8809snk4f7
10. (r,s) - Desethyl Oxybutynin
11. Schembl3364411
12. Chembl3544785
13. Chebi:174441
14. Dtxsid701001668
15. N-desethyloxybutynin, (+/-)-
16. 4-ethylamino-2-butynyl Cyclohexylphenyl-glycolate
17. Q27269871
18. 4-(ethylamino)but-2-yn-1-yl Cyclohexyl(hydroxy)phenylacetate
19. 4-(ethylamino)-2-butynyl Alpha-cyclohexyl-alpha-hydroxybenzeneacetate
20. Benzeneacetic Acid, Alpha-cyclohexyl-alpha-hydroxy-, 4-(ethylamino)-2-butynyl Ester
21. Benzeneacetic Acid, .alpha.-cyclohexyl-.alpha.-hydroxy-, 4-(ethylamino)-2-butyn-1-yl Ester
| Molecular Weight | 329.4 g/mol |
|---|---|
| Molecular Formula | C20H27NO3 |
| XLogP3 | 3.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 7 |
| Exact Mass | 329.19909372 g/mol |
| Monoisotopic Mass | 329.19909372 g/mol |
| Topological Polar Surface Area | 58.6 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 452 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ANALYTICAL
ABOUT THIS PAGE
A N-Desethyloxybutynin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of N-Desethyloxybutynin, including repackagers and relabelers. The FDA regulates N-Desethyloxybutynin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. N-Desethyloxybutynin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A N-Desethyloxybutynin supplier is an individual or a company that provides N-Desethyloxybutynin active pharmaceutical ingredient (API) or N-Desethyloxybutynin finished formulations upon request. The N-Desethyloxybutynin suppliers may include N-Desethyloxybutynin API manufacturers, exporters, distributors and traders.
click here to find a list of N-Desethyloxybutynin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A N-Desethyloxybutynin DMF (Drug Master File) is a document detailing the whole manufacturing process of N-Desethyloxybutynin active pharmaceutical ingredient (API) in detail. Different forms of N-Desethyloxybutynin DMFs exist exist since differing nations have different regulations, such as N-Desethyloxybutynin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A N-Desethyloxybutynin DMF submitted to regulatory agencies in the US is known as a USDMF. N-Desethyloxybutynin USDMF includes data on N-Desethyloxybutynin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The N-Desethyloxybutynin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of N-Desethyloxybutynin suppliers with USDMF on PharmaCompass.
N-Desethyloxybutynin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of N-Desethyloxybutynin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right N-Desethyloxybutynin GMP manufacturer or N-Desethyloxybutynin GMP API supplier for your needs.
A N-Desethyloxybutynin CoA (Certificate of Analysis) is a formal document that attests to N-Desethyloxybutynin's compliance with N-Desethyloxybutynin specifications and serves as a tool for batch-level quality control.
N-Desethyloxybutynin CoA mostly includes findings from lab analyses of a specific batch. For each N-Desethyloxybutynin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
N-Desethyloxybutynin may be tested according to a variety of international standards, such as European Pharmacopoeia (N-Desethyloxybutynin EP), N-Desethyloxybutynin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (N-Desethyloxybutynin USP).
LOOKING FOR A SUPPLIER?
